Table 2.
High risk | Low risk |
---|---|
Tumor >5cm | Tumor <5cm |
Norepinephrine secretion | Epinephrine secretion |
Paraganglioma* | Pheochromocytoma |
Older age (sporadic) | Younger age (sporadic and certain genetic groups) |
SDHB, FH, SLC25A11 germline mutation | VHL, RET mutation |
ATRX, TERT, MAML3 somatic disruptions | - |
excluding head and neck paragangliomas, which have intrinsically low risk of metastasis